BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2021 8:37:41 AM | Browse: 513 | Download: 770
 |
Received |
|
2021-02-13 08:47 |
|
Peer-Review Started |
|
2021-02-13 08:50 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-06 01:07 |
|
Revised |
|
2021-04-12 11:07 |
|
Second Decision |
|
2021-06-22 14:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-06-22 14:30 |
|
Articles in Press |
|
2021-06-22 14:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-11-23 08:30 |
|
Typeset the Manuscript |
|
2021-12-06 06:51 |
|
Publish the Manuscript Online |
|
2021-12-25 08:37 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biology |
| Manuscript Type |
Opinion Review |
| Article Title |
Stem cell-derived biofactors fight against coronavirus infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohammadreza Ardalan, Leila Chodari, Sepideh Zununi Vahed, Seyed Mahdi Hosseiniyan Khatibi, Aziz Eftekhari, Soodabeh Davaran, Magali Cucchiarini, Leila Roshangar and Elham Ahmadian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Elham Ahmadian, PhD, Assistant Professor, Kidney Research Center, Tabriz University of Medical Sciences, Golgasht Avenue, Tabriz 5166614766, Iran. ahmadian.l.h.m@gamil.com |
| Key Words |
COVID-19; Secretome; Mesenchymal stem cell; Exosome; Stem cell; Biofactors |
| Core Tip |
The world has witnessed unbelievable damage from the coronavirus disease 2019 (COVID-19) pandemic. The rapid propagation of the disease requires emerging therapeutical strategies. The central role of the immune system during the infection highlights the importance of a balanced immune response in order to prohibit overexaggerated responses and further multiorgan dysfunctions. Stem cell and stem cell-derived secretome-related therapies have gained increasing momentum in the treatment of a broad range of diseases in the past decade. In particular, the immunomodulatory properties of stem cell-derived biofactors could be a new avenue in the treatment of COVID-19 patients. |
| Publish Date |
2021-12-25 08:37 |
| Citation |
Ardalan M, Chodari L, Zununi Vahed S, Hosseiniyan Khatibi SM, Eftekhari A, Davaran S, Cucchiarini M, Roshangar L, Ahmadian E. Stem cell-derived biofactors fight against coronavirus infection. World J Stem Cells 2021; 13(12): 1813-1825 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i12/1813.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i12.1813 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
